A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo
Disease and Therapeutics · 2026 · 2 · 100006
DOI: 10.1016/j.dist.2026.100006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease and Therapeutics, 2026. Verfasst von Jarrett J. Adams und 14 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brookhaven National Laboratory, National Institute of General Medical Sciences, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Brookhaven National Laboratory
- National Institute of General Medical Sciences
- National Institutes of Health
- U.S. Department of Energy
- Office of Science
- Biological and Environmental Research
Zitieren
APA
Adams, J. J., Blazer, L. L., Chen, G., Chung, J., Mallette, E., Singer, A. U., Mendiratta, S. K., Bandyopadhyay, S., Singh, A. K., Kalita, P., Karimi, M., Cardarelli, L., Geyer, C. R., Michnick, S. W., & Sidhu, S. S. (2026). A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo. Disease and Therapeutics, 2, 100006. https://doi.org/10.1016/j.dist.2026.100006
Vancouver
Adams JJ, Blazer LL, Chen G, Chung J, Mallette E, Singer AU, et al. A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo. Disease and Therapeutics. 2026;2:100006. doi:10.1016/j.dist.2026.100006
BibTeX
@article{Adams2026,
author = {Adams, Jarrett J. and Blazer, Levi L. and Chen, Gang and Chung, Jacky and Mallette, Evan and Singer, Alexander U. and Mendiratta, Sanjeev K. and Bandyopadhyay, Sanjay and Singh, Arun K. and Kalita, Pankaj and Karimi, Minoo and Cardarelli, Lia and Geyer, C. Ronald and Michnick, Stephen W. and Sidhu, Sachdev S.},
title = {A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo},
journal = {Disease and Therapeutics},
year = {2026},
volume = {2},
pages = {100006},
doi = {10.1016/j.dist.2026.100006}
}
EUVIMED